CD38 and neoplasm: In addition, the numbers and expression of CD38+ MDSC were diminished by PD-1 antibody compared to IgG2a treatment in tumor-bearing Shp2f/f mice, but not in Shp2f/fLysMCre mice (Fig. 2d–f).